One of our primary goals at NeuroCure is to see the insights of basic science translated into clinical application. Through an integrative framework, we support the facilitation and development of cutting-edge therapies and new diagnostic approaches and technologies. By dovetailing outstanding basic and clinical research with expertise in conducting clinical studies, NeuroCure endeavors to find and improve treatments for a wide range of neurological diseases such as stroke, multiple sclerosis, Alzheimer's disease and dementia, and psychiatric disorders like autism, depression, schizophrenia, and addiction.

The NeuroCure Clinical Research Center (NCRC) was founded in 2008 to provide patients with the fastest possible access to new therapeutic and diagnostic options. Today, NCRC researchers are active in areas of cerebrovascular diseases, neuroinflammation, neurodegeneration, and disturbances in functional network structures. Clinical studies targeting the following diseases are also currently being carried out at the NCRC:

  • Stroke
  • Multiple sclerosis
  • Alzheimer’s disease and dementia
  • Epilepsy
  • Developmental disturbances of the nervous system

For more information, please visit our Clinical Research Center.